Antitumor agents. Part 202: Novel 2'-amino chalcones: Design, synthesis and biological evaluation

Bioorganic and Medicinal Chemistry Letters

Volumn 10, Issue 8, 2000, Pages 699-701

  Xia, Yi ^a   Yang, Zheng Yu ^a   Xia, Peng ^a   Bastow, Kenneth F ^a   Nakanishi, Yuka ^a   Lee, Kuo Hsiung ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2' AMINO CHALCONE; ACETOPHENONE DERIVATIVE; ALDEHYDE; CHALCONE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CATALYSIS; DRUG CYTOTOXICITY; DRUG SYNTHESIS; EPIDERMOID TUMOR; GLIOBLASTOMA; HUMAN; HUMAN CELL; LUNG CARCINOMA; MELANOMA CELL; MULTIDRUG RESISTANCE; NASOPHARYNX; OSTEOSARCOMA CELL; OVARY CANCER; POLYMERIZATION; STRUCTURE ACTIVITY RELATION; TUMOR CELL LINE;

AMINES; ANTINEOPLASTIC AGENTS; CHALCONE; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; TUMOR CELLS, CULTURED;

EID: 0034678788     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(00)00072-X     Document Type: Article

References (18)

1. Li R., Kenyon G.L., Cohen F.E., Chen X., Gong B., Dominguez J.N., Davidson E., Kurzban G., Miller R.E., Nuzman E.O. J. Med. Chem. 38:1995;5031.
2. Ballesteros J.F., Sanz M.J., Ubeda A., Miranda M.A., Iborra S., Paya M., Alcaraz M.J. J. Med. Chem. 38:1995;2794.
3. Dimmock J.R., Kandepu N.M., Hetherington M., Quail J.W., Pugazhenthi U., Sudom A.M., Chamankhah M., Rose P., Pass E., Allen T.M., Halleran S., Szydlowski J., Mutus B., Tannous M., Manavathu E.K., Myers T.G., Clercq E.D., Balzarini J. J. Med. Chem. 41:1998;1014.
4. Yit C.C., Das N.P. Cancer. Lett. 82:1994;65.
5. Satomi Y. Int. J. Cancer. 55:1993;506.
6. Wattenberg L.W., Coccia J.B., Galhaith A.R. Cancer Lett. 83:1994;165.
7. Dinkova-Kostova A.T., Abeygunawardana C., Talalay P. J. Med. Chem. 41:1998;5287.
8. Edwards M.L., Stemerick D.M., Sunkara P.S. J. Med. Chem. 33:1990;1948.
9. Li L., Wang H.K., Kuo S.C., Wu T.S., Lednicer D., Lin C., Hamel E., Lee K.H. J. Med. Chem. 37:1994;3400.
10. Li L., Wang H.K., Kuo S.C., Wu T.S., Lednicer D., Lin C., Hamel E., Lee K.H. J. Med. Chem. 37:1994;1126.
11. Xia Y., Yang Z.Y., Xia P., Bastow K., Tachibana Y., Kuo S.C., Hamel E., Hackl T., Lee K.H. J. Med. Chem. 41:1998;1155.
12. Lee K.H., Huang E.S., Piantadosi C., Pagano J., Geissman T.A. Cancer Res. 31:1971;1649.
13. Dimmock J.R., Raghavan S.K., Logan B.M., Bigam G.E. Eur. J. Med. Chem. 18:1983;248.
14. Benvenuto J.A., Connor T.H., Monteith D.K., Laidlaw J.L., Adams S.C., Matney T.S., Theiss J.C. J. Pharm. Sci. 82:1993;988.
15. Lee K.H., Hall I.H., Starness C.D., Elgebaly S.A., Waddell T.G., Hadgraft R.T., Ruffner C.G., Weidner I. Science. 196:1977;533.
16. Dhar D.N. The Chemistry of Chalcones and Related Compounds. 1981;John Wiley and Sons, New York.
17. +) 297.10.
18. The cytotoxic assay was performed previously as described in ref 11.